75
64
Growth Score 75 in past quarter
-7 pts
Heat Score 64 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
308609
Tactogen is a biopharma startup that develops empathogen medicines.
Matthew Baggott, Ph.D.: Co-Founder and CEOPast Role: Genentech, Director of Data Science & Engineering
About the Company
Tactogen is a biopharma startup that develops empathogen medicines.
The startup company offers drug discovery methods, novel molecules, and pharmaceutical preparations that focus on one goal: enabling safer take-home prescription empathogens.
It is headquartered in Palo Alto, California in 2020 by Ph.D. neuroscientist Matthew Baggott and deeptech
serial entrepreneur Luke Pustejovsky.